User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 14 results.
    • Speech
    Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients
    Vander Cruyssen, B. Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Van Looy, S. Westhovens, Rene[UCL] Van den Bosch, F. Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaeger, N. Geldhof, A. Boulart, L De Keyser, F. (2005) Annual European Congress of Rheumatology — Vienna (Austria)
    • Journal article
    Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA? Reply
    Durez, Patrick[UCL] Toukap, AN Lauwerys, Bernard[UCL] Manicourt, Daniel[UCL] Devogelaer, Jean-Pierre[UCL] Houssiau, Frédéric[UCL] Verschueren, P. Westhovens, Rene[UCL] (2005) Annals of the Rheumatic Diseases — Vol. 64, no. 1, p. 172-172 (2005)
    • Journal article
    Timing of DAS28 in infliximab therapy: reply
    Durez, Patrick[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Vastesaeger, N. Geldhof, A. Westhovens, Rene[UCL] (2005) Rheumatology — Vol. 44, no. 9, p. 1204-1204 (2005)
    • Journal article
    A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
    Durez, Patrick[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Vastesaeger, N. Geldhof, A. Westhovens, Rene[UCL] (2005) Rheumatology — Vol. 44, no. 4, p. 465-468 (2005)
    • Journal article
    74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis.
    Delabaye, Isabelle De Keyser, Filip REMITRACT study group Houssiau, Frédéric[UCL] Dufour, Jean-Pol[UCL] Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] (2010) Arthritis Research and Therapy — Vol. 12, no. 3, p. R121 [1-12] (2010)
    • Journal article
    A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.
    De Mits, Sophie Lenaerts, Jan Vander Cruyssen, Bert Mielants, Herman Westhovens, René Durez, Patrick[UCL] Elewaut, Dirk Be-Raise study group Houssiau, Frédéric[UCL] Devogelaer, Jean-Pierre[UCL] Lauwerys, Bernard[UCL] Nzeusseu Toukap, Adrien[UCL] Vanden Bergh, Marc[UCL] Dufour, Jean-Pol[UCL] Manicourt, Daniel[UCL] (2016) PLoS One — Vol. 11, no. 11, p. e0166607 [1-10] (2016)
    • Speech
    Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis.
    Durez, Patrick[UCL] Vandenbosch, F. Corluy, L Van den Bossche, N Schuerwegh, A De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Westhovens, Rene[UCL] (2002) 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — NEW ORLEANS (Louisiana)
    • Speech
    Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA)
    Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Vander Cruyssen, B. Vandenbosch, F. Vastesaeger, N. Geldhof, A. De Keyser, F. Verbruggen, L. De Clerck, L. Peretz, A. Malaise, Michel Van Heuverbeke, F. Westhovens, Rene[UCL] (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Speech
    Detection of vertebral fractures on routine chest rays: The stof study
    Goemaere, S. Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Boutsen, Yves Vanslembrouck, J. Nisolle, Jean-François[UCL] Verstraete, K. Kaufman, J. M. (2006) 11th Conference of the National-Osteoporosis-Society — Harrogate (England)
    • Journal article
    Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails? Reply
    Durez, Patrick[UCL] Nzeusseu, TA Lauwerys, Bernard[UCL] Manicourt, Daniel[UCL] Devogelaer, Jean-Pierre[UCL] Houssiau, Frédéric[UCL] Verschueren, P. Westhovens, Rene[UCL] (2005) Annals of the Rheumatic Diseases — Vol. 64, no. 3, p. 512-512 (2005)
    • Journal article
    A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez, Patrick[UCL] Nzeusseu Toukap, A Lauwerys, Bernard[UCL] Manicourt, Daniel[UCL] Verschueren, P. Westhovens, Rene[UCL] Devogelaer, Jean-Pierre[UCL] Houssiau, Frédéric[UCL] (2004) Annals of the rheumatic diseases — Vol. 63, no. 9, p. 1069-74 (2004)
    • Speech
    A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks is effective: A Belgian prospective study
    Westhovens, Rene[UCL] Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Vastesaeger, N. (2004) Annual European Congress of Rheumatology (EULAR 2004) — Berlin (Germany)
    • Speech
    Bone mineral density in severe and refractory rheumatoid arthritis patients treated with infliximab
    Durez, Patrick[UCL] Houssiau, Frédéric[UCL] Depresseux, Geneviève[UCL] Caussin, E Zneusseu, A Devogelaer, Jean-Pierre[UCL] (2003) 1ST Joint meeting of the International-Bone-and-Mineral-Society/Japanese-Society-for-Bone-and-Mineral-Research — OSAKA (Japan)
    • Journal article
    Les inhibiteurs du TNFα en 2004
    Pierard, Sophie[UCL] Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] (2004) Louvain médical — Vol. 123, no. 8, p. 286-295 (2004)